• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

ZeOmega Integrates with McKesson’s InterQual Connect

by Jasmine Pennic 05/25/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

InterQual Connect

ZeOmega Inc. has announced an agreement to integrate ZeOmega’s Jiva™ population health management solution with McKesson’s InterQual® Connect authorization and connectivity solution to fully automate pre-authorization for payers and providers. The integration marks ZeOmega’s Jiva as the first partner to tap InterQual Connect’s cloud connectivity to expand automated authorization to include requests requiring a medical review and simplify pre-auths for their customers.

Without leaving their easy chair, providers will be able to click a button and get an instant authorization from health plans that use Jiva with InterQual Connect. No paperwork, no faxes, no phone calls, no switching to another software system or duplicative reviews. Best of all, this helps reduce costs, speed care for patients and payment for providers.

Now health plans and ACOs that use Jiva can expand automated authorization to include requests requiring a medical review, without leaving their Jiva system. They can use InterQual Connect’s secure connectivity to receive the InterQual medical review along with the authorization request from network providers and, in most cases, automatically return the authorization determination without manual intervention. By eliminating duplicative reviews and manual work, health plans can reduce administrative costs and speed authorizations while ensuring appropriate care.

“Prior authorization can be a costly burden for payers and providers alike, and can slow care delivery,” said Nilo Mehrabian, vice president of product management, Decision Management, at McKesson Health Solutions. “Bringing InterQual Connect to Jiva means ZeOmega’s customers can streamline their workflow with the integrated medical review and enhanced automated authorization. Making utilization management (UM) more efficient is crucial for a world increasingly moving to value-based care.”

InterQual Connect is part of the InterQual product line, McKesson’s flagship decision support solution. InterQual Criteria help payers and providers ensure appropriate care across the medical and behavioral health continuums of care, which helps improve quality and reduce unnecessary cost.

The InterQual clinical development team synthesizes the current, best evidence into a fully referenced decision support tool that is reviewed and updated annually. InterQual’s development process, honed over nearly 40 years, is founded on rigorous review of the literature, and includes extensive peer review by practicing clinical experts across the United States.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: InterQual Connect, mckesson, ZeOmega

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |